Elicio Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| KNOLL CAPITAL MANAGEMENT, LLC | 02/17/2026 | 630.92 K | $5.02 M | 0.00% | 3.78% |
| VANGUARD GROUP INC | 01/29/2026 | 496.90 K | $3.96 M | 4.86% | 2.98% |
| SIO CAPITAL MANAGEMENT, LLC | 02/17/2026 | 296.90 K | $2.36 M | 100.00% | 1.78% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/17/2026 | 138.76 K | $1.10 M | -6.29% | 0.83% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 132.52 K | $1.06 M | 2.18% | 0.79% |
| MARSHALL WACE, LLP | 02/13/2026 | 117.20 K | $932.91 K | 35.44% | 0.70% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 64.05 K | $509.85 K | -46.72% | 0.38% |
| 683 CAPITAL MANAGEMENT, LLC | 02/17/2026 | 56.44 K | $449.28 K | 100.00% | 0.34% |
| NORTHERN TRUST CORP | 02/17/2026 | 52.77 K | $420.04 K | -1.52% | 0.32% |
| STATE STREET CORP | 02/13/2026 | 46.30 K | $368.55 K | 20.89% | 0.28% |
| BLACKROCK, INC. | 02/12/2026 | 45.18 K | $359.63 K | 2.23% | 0.27% |
| CITADEL ADVISORS LLC | 02/17/2026 | 35.20 K | $280.19 K | 67.62% | 0.21% |
| UBS GROUP AG | 01/29/2026 | 32.02 K | $254.85 K | 356.13% | 0.19% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 28.11 K | $223.76 K | -42.24% | 0.17% |
| CM MANAGEMENT, LLC | 02/02/2026 | 25.00 K | $199.00 K | 316.67% | 0.15% |
| OMERS ADMINISTRATION CORP | 02/13/2026 | 23.50 K | $187.06 K | 100.00% | 0.14% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 20.22 K | $160.92 K | 100.00% | 0.12% |
| CITADEL ADVISORS LLC | 02/17/2026 | 18.40 K | $146.46 K | 100.00% | 0.11% |
| QUADRATURE CAPITAL LTD | 02/17/2026 | 17.16 K | $136.59 K | 100.00% | 0.10% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 16.66 K | $132.63 K | 100.00% | 0.10% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 02/17/2026 | 15.83 K | $125.98 K | 100.00% | 0.09% |
| MORGAN STANLEY | 02/13/2026 | 14.55 K | $115.84 K | 847.46% | 0.09% |
| MEYER HANDELMAN CO | 01/15/2026 | 13.90 K | $110.64 K | 0.00% | 0.08% |
| JEFFERIES FINANCIAL GROUP INC. | 02/09/2026 | 11.94 K | $95.06 K | 129.65% | 0.07% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 11.65 K | $92.75 K | 100.00% | 0.07% |
| HIGHTOWER ADVISORS, LLC | 02/06/2026 | 11.19 K | $89.04 K | 100.00% | 0.07% |
| SUMMIT FINANCIAL, LLC | 02/13/2026 | 10.01 K | $79.68 K | 100.00% | 0.06% |
| WILEY BROS.-AINTREE CAPITAL, LLC | 02/17/2026 | 10.00 K | $79.60 K | 0.00% | 0.06% |
| MOODY LYNN & LIEBERSON, LLC | 01/15/2026 | 10.00 K | $79.60 K | 0.00% | 0.06% |
| MAYFLOWER FINANCIAL ADVISORS, LLC | 01/13/2026 | 10.00 K | $79.60 K | 0.00% | 0.06% |
| CIBC PRIVATE WEALTH GROUP, LLC | 02/12/2026 | 7.00 K | $55.72 K | 0.00% | 0.04% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 5.67 K | $45.12 K | 100.00% | 0.03% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 02/12/2026 | 1.55 K | $12.37 K | 0.00% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 1.16 K | $9.21 K | -67.73% | 0.01% |
| FARTHER FINANCE ADVISORS, LLC | 01/23/2026 | 705 | $5.61 K | 10.16% | 0.00% |
| GROUP ONE TRADING, L.P. | 02/12/2026 | 323 | $2.57 K | 100.00% | 0.00% |
| ROYAL BANK OF CANADA | 02/17/2026 | 219 | $2.00 K | 100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 200 | $1.59 K | 0.00% | 0.00% |
| FORTITUDE FAMILY OFFICE, LLC | 01/15/2026 | 93 | $740 | 100.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 02/03/2026 | 82 | $653 | 0.00% | 0.00% |
| JEFFERIES FINANCIAL GROUP INC. | 02/09/2026 | 0 | $0 | -100.00% | 0.00% |
| CITIGROUP INC | 02/13/2026 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| SIMPLEX TRADING, LLC | 02/11/2026 | 0 | $0 | -100.00% | 0.00% |
| CAPTION MANAGEMENT, LLC | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| CRESSET ASSET MANAGEMENT, LLC | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Elicio Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 49 institutional investors and hedge funds held shares of Elicio Therapeutics Inc.. The most heavily invested institutionals were:
VANGUARD FIDUCIARY TRUST CO: 69,189
UBS Group AG: 33,769
IRIDIAN ASSET MANAGEMENT LLC/CT: 30,051
CM Management, LLC: 25,000
MEYER HANDELMAN CO: 13,899
KINGSWOOD WEALTH ADVISORS, LLC: 13,800
12.46% of Elicio Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 2.27 M shares in the last 24 months. This purchase volume represents approximately $26.71 M in transactions.